IL100887A - Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing them - Google Patents
Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing themInfo
- Publication number
- IL100887A IL100887A IL10088792A IL10088792A IL100887A IL 100887 A IL100887 A IL 100887A IL 10088792 A IL10088792 A IL 10088792A IL 10088792 A IL10088792 A IL 10088792A IL 100887 A IL100887 A IL 100887A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- pyrid
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102997A GB9102997D0 (en) | 1991-02-13 | 1991-02-13 | Therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL100887A0 IL100887A0 (en) | 1992-11-15 |
| IL100887A true IL100887A (en) | 1996-01-19 |
Family
ID=10689943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10088792A IL100887A (en) | 1991-02-13 | 1992-02-06 | Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing them |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5358953A (cs) |
| EP (1) | EP0572425B1 (cs) |
| JP (1) | JP2506541B2 (cs) |
| KR (1) | KR970005302B1 (cs) |
| CN (1) | CN1040326C (cs) |
| AT (1) | ATE109482T1 (cs) |
| AU (1) | AU650322B2 (cs) |
| BR (1) | BR9205615A (cs) |
| CA (1) | CA2099381C (cs) |
| CZ (1) | CZ280504B6 (cs) |
| DE (1) | DE69200304T2 (cs) |
| DK (1) | DK0572425T3 (cs) |
| EG (1) | EG20085A (cs) |
| ES (1) | ES2059212T3 (cs) |
| FI (1) | FI933531A7 (cs) |
| GB (1) | GB9102997D0 (cs) |
| HU (2) | HUT65947A (cs) |
| IE (1) | IE65125B1 (cs) |
| IL (1) | IL100887A (cs) |
| MX (1) | MX9200589A (cs) |
| MY (1) | MY108437A (cs) |
| NO (1) | NO300592B1 (cs) |
| NZ (1) | NZ241597A (cs) |
| PL (1) | PL169304B1 (cs) |
| RU (1) | RU2114845C1 (cs) |
| TW (1) | TW227000B (cs) |
| WO (1) | WO1992014734A1 (cs) |
| YU (1) | YU48238B (cs) |
| ZA (1) | ZA921005B (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2042421B1 (es) * | 1992-05-22 | 1994-08-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina. |
| AU3186395A (en) * | 1994-08-10 | 1996-03-07 | British Biotech Pharmaceuticals Limited | Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists |
| ES2087038B1 (es) * | 1994-11-07 | 1997-03-16 | Uriach & Cia Sa J | Nuevas piperidinas con actividad antagonista del paf. |
| US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
| GB9508748D0 (en) * | 1995-04-28 | 1995-06-14 | British Biotech Pharm | Benzimidazole derivatives |
| MX9707187A (es) * | 1995-08-05 | 1997-11-29 | British Biotech Pharm | Derivados de imidazopiridina. |
| SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
| JP5048201B2 (ja) | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
| ES2575563T3 (es) | 2003-05-15 | 2016-06-29 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
| US7687515B2 (en) * | 2006-01-17 | 2010-03-30 | N.V. Organon | 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| TWI429641B (zh) | 2008-01-30 | 2014-03-11 | Nippon Zoki Pharmaceutical Co | 哌啶衍生物 |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CN103619839B (zh) * | 2011-06-28 | 2016-06-01 | 福建省闽东力捷迅药业有限公司 | 抗-变态反应的苯并环庚并噻吩衍生物 |
| MY172699A (en) | 2011-10-10 | 2019-12-10 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| WO2013055734A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| MX355446B (es) * | 2011-10-28 | 2018-04-18 | Ampio Pharmaceuticals Inc | Tratamiento de rinitis. |
| CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| EP4066836A1 (en) | 2014-08-18 | 2022-10-05 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES |
| CN113880801A (zh) * | 2020-07-03 | 2022-01-04 | 合肥医工医药股份有限公司 | 一类三环化合物、其制备方法及其医药用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL132137C (cs) * | 1963-04-24 | |||
| WO1989008653A1 (en) * | 1988-03-15 | 1989-09-21 | G.D. Searle & Co. | 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS |
| JP2511550B2 (ja) * | 1988-04-28 | 1996-06-26 | シェリング・コーポレーション | 融合多環式化合物、組成物、製造方法およびpaf拮抗、抗ヒスタミンおよび/または抗炎症剤としてのその使用 |
| US5250681A (en) * | 1988-06-02 | 1993-10-05 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| US5114919A (en) * | 1990-02-26 | 1992-05-19 | Merck & Co., Inc. | Adjuncts in cancer chemotherapy |
| DK0533695T3 (da) * | 1990-05-09 | 1995-01-09 | Pfizer | Imidazo(4,5-c)pyridiner med PAF-antagonistaktivitet |
-
1991
- 1991-02-13 GB GB919102997A patent/GB9102997D0/en active Pending
-
1992
- 1992-01-24 HU HU9302327A patent/HUT65947A/hu unknown
- 1992-01-24 BR BR9205615A patent/BR9205615A/pt not_active Application Discontinuation
- 1992-01-24 WO PCT/EP1992/000163 patent/WO1992014734A1/en active IP Right Grant
- 1992-01-24 PL PL92300296A patent/PL169304B1/pl unknown
- 1992-01-24 FI FI933531A patent/FI933531A7/fi not_active Application Discontinuation
- 1992-01-24 US US08/087,736 patent/US5358953A/en not_active Expired - Fee Related
- 1992-01-24 KR KR1019930702352A patent/KR970005302B1/ko not_active Expired - Fee Related
- 1992-01-24 ES ES92902889T patent/ES2059212T3/es not_active Expired - Lifetime
- 1992-01-24 JP JP4503504A patent/JP2506541B2/ja not_active Expired - Fee Related
- 1992-01-24 DE DE69200304T patent/DE69200304T2/de not_active Expired - Fee Related
- 1992-01-24 EP EP92902889A patent/EP0572425B1/en not_active Expired - Lifetime
- 1992-01-24 AT AT92902889T patent/ATE109482T1/de not_active IP Right Cessation
- 1992-01-24 CA CA002099381A patent/CA2099381C/en not_active Expired - Fee Related
- 1992-01-24 AU AU11683/92A patent/AU650322B2/en not_active Ceased
- 1992-01-24 DK DK92902889.2T patent/DK0572425T3/da active
- 1992-01-24 RU RU93054165A patent/RU2114845C1/ru active
- 1992-02-06 IL IL10088792A patent/IL100887A/en not_active IP Right Cessation
- 1992-02-10 TW TW081100891A patent/TW227000B/zh active
- 1992-02-10 EG EG8792A patent/EG20085A/xx active
- 1992-02-11 MX MX9200589A patent/MX9200589A/es unknown
- 1992-02-12 YU YU14392A patent/YU48238B/sh unknown
- 1992-02-12 MY MYPI92000223A patent/MY108437A/en unknown
- 1992-02-12 NZ NZ241597A patent/NZ241597A/en unknown
- 1992-02-12 IE IE920449A patent/IE65125B1/en not_active IP Right Cessation
- 1992-02-12 CZ CS92425A patent/CZ280504B6/cs not_active IP Right Cessation
- 1992-02-12 ZA ZA921005A patent/ZA921005B/xx unknown
- 1992-02-13 CN CN92100974A patent/CN1040326C/zh not_active Expired - Fee Related
-
1993
- 1993-08-13 NO NO932889A patent/NO300592B1/no unknown
-
1995
- 1995-06-09 HU HU95P/P00175P patent/HU211202A9/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0572425B1 (en) | Imidazopyridine paf/h 1 antagonists | |
| US4668686A (en) | Imidazoquinoline antithrombrogenic cardiotonic agents | |
| RU2285693C2 (ru) | Производные пиридина и хинолина, способ их получения, фармацевтическая композиция, применение соединений для лечения заболеваний, ассоциированных с dpp-iv | |
| US4432979A (en) | Pyridone compounds | |
| CH639847A5 (it) | Cicloalchiltriazoli. | |
| US5250531A (en) | Dihydropyrimidine antiallergy agents | |
| US5639756A (en) | Benzimidazole compounds | |
| JP2003527426A (ja) | トロンビン阻害薬 | |
| US4853392A (en) | Fused 1,4-dihydropyridines as antiallergy and antiinflammatory agents | |
| PT93603A (pt) | Processo para a preparacao de agentes anti-alergicos de di-hidropirina | |
| JPS63139167A (ja) | ジヒドロピリジン抗アレルギー及び抗炎症剤 | |
| US5114944A (en) | 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects | |
| FI101225B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso£4,5-c|py rid-1-yylijohdannaisten valmistamiseksi | |
| JPH064637B2 (ja) | 新規なインドール誘導体 | |
| JPH0420916B2 (cs) | ||
| US4593028A (en) | 5-hetero aryl-substituted-2-pyridones useful as cardiotonic agents for treatment of congestive heart failure | |
| JPH05507932A (ja) | イミダゾピリジンpaf拮抗薬 | |
| PT100223B (pt) | Processo para a preparacao de imidazopiridinas antagonistas de paf/h1 | |
| EP0680953A1 (en) | 1-[Styryl]- and 1-[2'-(heteroaryl)-ethenyl]-isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them | |
| KR20070094949A (ko) | 2-(시클릭 아미노카르보닐)인돌린 유도체 및 그것을함유하는 약제학적 조성물 | |
| JPS5865290A (ja) | 新規ベンゾジアゼピン化合物とその中間体 | |
| JPH08807B2 (ja) | 新規ホモベラトリルアミン誘導体及びその製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |